RE:Also keep in focus the NDA (new drug application) cos' we Yes, generics are cheaper..I continue repeating..Epidiolex, pure cannabidol, a.k.a CBD..no different than LABS CBD 100 oil cost insurers between 1700-2200 usd...if the generic has half this price it represents 10-15x the current sell price of our CBD 100 oil...plenty of gravy to split with our partner...VERY lucrative..I do agree it's likely the NEW DRUG APPLICATION will be approved for marketing first...and from the timelines provided from the FDA website sooner than later...Hopefully anyday hence the commentary from management in regards to all equity M&A opportunities..furthermore once approved for marketing I would expect a substantial investment from our global pharma partner like what was seen NOV 22 when charlottes web got a 20% equity buy in from B.A.T..(60 million)much higher than market valuation...a major Global pharmaceutical Corp will want a seat on the board.